Qing Li

Dr. Qing Li

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2025 in Science
Verified
Journal Article
Closed access
BZBoxue Zhang
Boxue Zhang
JLJunsheng Luo
Junsheng Luo
HYHaomiao Yin
Haomiao Yin
QLQing Li
Qing Li
SSSiqi Sun
Siqi Sun
SPSo Min Park
So Min Park
Monolithic perovskite/silicon tandem solar cells surpass the power-conversion efficiency limits of single-junction solar cells but face challenges in operational stability. We identified fill factor diminution as a key performance-loss mode in the state-of-the-art tandem architecture. We reveal that widely used hole-selective molecular contacts, which enhance tandem cell performance, undergo thermal degradation that undermines charge transport. At elevated temperatures, the resistance of conventional monomeric contacts increases by about sixfold because of thermal-induced disorder. To stabilize interfacial structures, we introduce in situ synthesized cross-linked molecular contacts based on Schiff base linkages. One-square-centimeter perovskite/silicon tandem solar cells achieved power-conversion efficiencies exceeding 34% (33.61% certified), and three independent devices retained 96.2 ± 1.7% of their initial performance after about 1200-hour maximum power point operation under AM1.5G illumination at 65°C.

6 September 2016 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
QLQing Li
Qing Li
LHLi Han
Li Han
BZBin Zhang
Bin Zhang
JZJinpei Zhou
Jinpei Zhou
HZHuibin Zhang
Huibin Zhang
A series of triazole based uracil derivatives were designed and synthesized as novel DPP-4 inhibitors. Compound A01 was identified as a lead compound for SAR studies focused on the structural modification at the S2′ subsite of DPP-4. The novel analogues A02–A25 were obtained by modifying the substituents at the phenyl group, and B01–B09, by introducing the carbonyl group. On screening in DPP-4, compounds B03, B04 and B08 showed a significant improvement in DPP-4 inhibitory activities compared to compound A01 and showed comparable activities to the marketed DPP-4 inhibitor, alogliptin. Docking studies revealed new favorable binding modes of designed compounds in the S2′ subsite and proved that structural modifications in the S2′ subsite were an effective option to increase the inhibition of DPP-4. In vitro DPP-8 and DPP-9 tests indicated that all compounds showed excellent selectivity against DPP-8 and DPP-9. Further in vivo evaluation showed that compound B04 could significantly improve oral glucose tolerance in ICR mice and dose-dependently reduced glucose levels in type 2 diabetic C57BL/6 mice. These data suggest that compound B04 could be a promising DPP-4 inhibitor for future treatment of T2DM.

12 April 2015 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
QLQing Li
Qing Li
MZMuxing Zhou
Muxing Zhou
LHLi Han
Li Han
QCQing Cao
Qing Cao
XWXinning Wang
Xinning Wang
HZHuibin Zhang
Huibin Zhang

1 December 2017 in Bioorganic Chemistry
Verified
Journal Article
Closed access
XDXiaoyan Deng
Xiaoyan Deng
LHLi Han
Li Han
JZJinpei Zhou
Jinpei Zhou
HZHuibin Zhang
Huibin Zhang
QLQing Li
Qing Li

21 July 2014 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
QLQing Li
Qing Li
JXJunhao Xing
Junhao Xing
HCHaibo Cheng
Haibo Cheng
HWHui Wang
Hui Wang
JWJing Wang
Jing Wang
HZHuibin Zhang
Huibin Zhang

19 April 2022 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
WHWen-Bi Hu
Wen-Bi Hu
YQYan-Qing Qiu
Yan-Qing Qiu
WWWen-Yi Wei
Wen-Yi Wei
QLQing Li
Qing Li
YXYan-Jun Xu
Yan-Jun Xu